Clinical Trial Update: Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a bevacizumab-containing regimen before surgery for stage II-III rectal cancer; status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FLUOROURACIL (Fluorouracil)
• Leucovorin calcium (calcium folinate)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of Southern California | Conditions: Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum | Phase 2 | Status: UNKNOWN